Fedovapagon
- Generic Name
- Fedovapagon
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H34N4O3
- CAS Number
- 347887-36-9
- Unique Ingredient Identifier
- VX2GBO4I0V
- Background
Fedovapagon has been used in trials studying the treatment of Nocturia.
- Associated Conditions
- -
- Associated Therapies
- -
A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Vantia Ltd
- Target Recruit Count
- 43
- Registration Number
- NCT02537288
- Locations
- 🇩🇪
PAREXEL Early Phase Clinical Unit Berlin, Berlin, Germany
Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Vantia Ltd
- Target Recruit Count
- 29
- Registration Number
- NCT02440841
- Locations
- 🇩🇪
PAREXEL Early Phase Clinical Unit Berlin, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath